Literature DB >> 7264855

Pathological features of the eye in the oculocerebrorenal (Lowe) syndrome.

J Ginsberg, K E Bove, M H Fogelson.   

Abstract

We studied the eyes of a 13-year-old boy with Lowe syndrome and updated the microscopic ocular findings. These are interpreted as a mesoectodermal dysgenesis involving the anterior and posterior segment. The eye exhibits a greater variety of morphologic change than any other organ in Lowe syndrome. The microscopic findings, particularly in the lens, are highly suggestive of this disorder. The pathogenesis of the ocular and extraocular lesions in Lowe syndrome in unknown. Most of the ocular abnormalities are probably determined in the first two months of gestation and there is no apparent embryologic relation to extraocular abnormalities. Some manifestations of Lowe syndrome may be secondary to accumulation of polyamines, a class of compounds that includes cytotoxic byproducts of faulty dibasic amino acid metabolism.

Entities:  

Mesh:

Year:  1981        PMID: 7264855     DOI: 10.3928/0191-3913-19810701-05

Source DB:  PubMed          Journal:  J Pediatr Ophthalmol Strabismus        ISSN: 0191-3913            Impact factor:   1.402


  3 in total

1.  Anesthetic management for a patient with oculocerebrorenal (Lowe's) syndrome.

Authors:  Hisao Komatsu; Masatomo Sakakibara; Yutaka Yoshimura; Hiroyuki Kinoshita; Satoshi Yokono; Kenji Ogli
Journal:  J Anesth       Date:  1994-03       Impact factor: 2.078

2.  The significance of opthalmologic evaluation in the early diagnosis of inborn errors of metabolism: the Cretan experience.

Authors:  Daria P Tsagaraki; Athanasios E Evangeliou; Miltiadis Tsilimbaris; Martha G Spilioti; Eleni P Mihailidou; Christos Lionis; Ioannis Pallikaris
Journal:  BMC Ophthalmol       Date:  2002-04-11       Impact factor: 2.209

3.  Ocular Pathology of Oculocerebrorenal Syndrome of Lowe: Novel Mutations and Genotype-Phenotype Analysis.

Authors:  Emilie Song; Na Luo; Jorge A Alvarado; Maria Lim; Cathleen Walnuss; Daniel Neely; Dan Spandau; Alireza Ghaffarieh; Yang Sun
Journal:  Sci Rep       Date:  2017-05-04       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.